Viewing Study NCT06203457


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-22 @ 7:51 AM
Study NCT ID: NCT06203457
Status: COMPLETED
Last Update Posted: 2025-04-03
First Post: 2023-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome
Sponsor: argenx
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Sjögren's Syndrome View
Keywords: